Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angle Plc ADR (OP: ANPCY )

1.200 UNCHANGED
Streaming Delayed Price Updated: 10:50 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.200
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.200
Today's Range 1.200 - 1.200
52wk Range 0.7362 - 4.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
Via ACCESSWIRE
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
Via ACCESSWIRE

Performance

YTD
-70.00%
-70.00%
1 Month
+63.00%
+63.00%
3 Month
-6.25%
-6.25%
6 Month
-53.85%
-53.85%
1 Year
+6.24%
+6.24%

More News

Read More
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
Via ACCESSWIRE
Angle PLC Announces 100th Publication Supporting Parsortix System Use
Via ACCESSWIRE
Angle PLC Announces Half-year Report
Via ACCESSWIRE
Angle PLC Announces Exclusive agreement for DNA NGS panel
Via ACCESSWIRE
Angle PLC Announces Agreement with Recursion Pharmaceuticals
Via ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
Via ACCESSWIRE
Angle PLC - Data Supporting FDA Approval Published in Journal
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC Announces Result of 2024 Annual General Meeting
Via ACCESSWIRE
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
Via ACCESSWIRE
Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
Via ACCESSWIRE
Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
Via ACCESSWIRE
Angle PLC Announces New Commercial Agreement with Large Pharma
Via ACCESSWIRE
Angle PLC Announces New Commercial Agreement with AstraZeneca
Via ACCESSWIRE
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
Via ACCESSWIRE
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
Via ACCESSWIRE
Angle PLC Announces Parsortix at European Breast Cancer Conference
Via ACCESSWIRE
Angle PLC Announces Potential Utility in Precision Oncology
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC - Contract announcement with Eisai Inc.
Via ACCESSWIRE
Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery
Via ACCESSWIRE
Angle PLC Announces Broker Announcement
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.